Egle Therapeutics
- Biotech or pharma, therapeutic R&D
Spin out of the Institut Curie backed by a 40M€ Series A plus a research collaboration with Takeda, Egle Therapeutics is an emerging biotechnology company focused on developing first-in class immunotherapies targeting immune suppressor regulatory T-cells
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}